Additionally, multiple HER2-family ligands such as epidermal growth factor (EGF), amphiregulin (AREG), and neuregulin 1 (NRG1) are known to be overexpressed as well in trastuzumab-resistant GC cells [128]. The gene discussed is ERBB2; the disease is gastric cancer.